πŸ‡ΊπŸ‡Έ FDA
Patent

US 8865880

Identification of a novel BHD gene

granted A61KA61K38/00A61P

Quick answer

US patent 8865880 (Identification of a novel BHD gene) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P17/00